Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/26/2026 | Q4 | $3.9M | -- | -- | $0.54 | -- |
| 11/13/2025 | Q3 | $3.9M | $4.1M | -$0.10 | -$0.09 | -$0.01 |
| 08/14/2025 | Q2 | $3.9M | $4.1M | -$0.11 | -$0.09 | -$0.02 |
| 05/15/2025 | Q1 | $4.5M | $3M | -$0.14 | -$0.11 | -$0.03 |
| 12/31/2024 | Q4 | $8.4M | $4.8M | -$0.14 | -$0.08 | -$0.06 |
| 11/13/2024 | Q3 | $5.2M | $3.2M | -$0.12 | -$0.11 | -$0.01 |
| 08/13/2024 | Q2 | $4M | $513K | -$0.15 | -$0.10 | -$0.05 |
| 05/14/2024 | Q1 | -- | $1.1M | -$0.12 | -- | -- |
| 12/31/2023 | Q4 | -- | $684K | -$0.12 | -- | -- |
| 11/13/2023 | Q3 | -- | $368K | -$0.12 | -- | -- |
| 08/10/2023 | Q2 | -- | $809K | -$0.13 | -- | -- |
| 05/15/2023 | Q1 | -- | $130K | -$0.19 | -- | -- |
| 12/31/2022 | Q4 | -- | $574K | -$0.15 | -- | -- |
| 11/14/2022 | Q3 | -- | $599K | -$0.15 | -- | -- |
| 08/12/2022 | Q2 | -- | $185K | -$0.13 | -- | -- |
| 05/12/2022 | Q1 | -- | $142K | -$0.16 | -- | -- |
| 03/25/2022 | Q4 | -- | $142K | -$0.16 | -- | -- |
| 11/12/2021 | Q3 | -- | $142K | -$0.22 | -- | -- |
| 08/13/2021 | Q2 | -- | $141K | -$0.30 | -- | -- |
| 05/17/2021 | Q1 | -- | $139K | -$0.16 | -- | -- |
| 12/31/2020 | Q4 | -- | $140K | -$0.22 | -- | -- |
| 11/05/2020 | Q3 | -- | $139K | -$0.13 | -- | -- |
| 08/07/2020 | Q2 | -- | $148K | -$0.14 | -- | -- |
| 05/07/2020 | Q1 | -- | $114K | -$0.66 | -- | -- |
| 12/31/2019 | Q4 | -- | $111K | -$0.27 | -- | -- |
| 11/12/2019 | Q3 | -- | $110K | -$0.28 | -- | -- |
| 08/08/2019 | Q2 | -- | $111K | -$0.28 | -- | -- |
| 03/31/2019 | Q1 | -- | $109K | -$0.29 | -- | -- |
| 12/31/2018 | Q4 | -- | $111K | -$0.33 | -- | -- |
| 09/30/2018 | Q3 | -- | $112K | -$0.26 | -- | -- |
| 06/30/2018 | Q2 | -- | $109K | -$0.25 | -- | -- |
| 03/31/2018 | Q1 | -- | $108K | -$0.26 | -- | -- |
| 12/31/2017 | Q4 | -- | $110K | -$0.31 | -- | -- |
| 11/08/2017 | Q3 | -- | $111K | -$0.26 | -- | -- |
| 08/09/2017 | Q2 | -- | $108K | -$0.60 | -- | -- |
| 05/09/2017 | Q1 | -- | $108K | -$0.33 | -- | -- |
| 03/20/2017 | Q4 | -- | $109K | -$0.34 | -- | -- |
| 11/09/2016 | Q3 | -- | $120K | -$0.28 | -- | -- |
| 08/08/2016 | Q2 | -- | $108K | -$0.31 | -- | -- |
| 05/13/2016 | Q1 | -- | $75K | -$0.49 | -- | -- |
| 04/04/2016 | Q4 | -- | $21K | -$0.40 | -- | -- |
Cadiz, Inc. reported $4.1M worth of top line sales in its most recent quarter.
Cadiz, Inc. announced earnings per share of -$0.10 which represents a miss of analyst forecast a -$0.09 per share.
Cadiz, Inc. reported $830K that represents $0.01 per share over the last quarter.
Cadiz, Inc.'s earnings are forecast to decrease from -$0.53 per share to -$0.47 per share next year representing a decrease of -91.45%.
Cadiz, Inc.'s next earnings date is March 26, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.